Panax pseudoginseng var. notoginseng Wall. |
|
|
|
Botanical Name |
: |
Panax pseudoginseng var. notoginseng Wall. |
English
Name |
: |
Notoginseng, Sanchi ginseng, San-qi ginseng, South China ginseng, Tien-qi ginseng, Yunnan ginseng |
Synonym(s) |
: |
Aralia quinquefolia (Linnaeus) Decaisne & Planchon var. notoginseng Burkill, Panax pseudoginseng Wallich var. notoginseng (Burkill) G. Hoo & C. J. Tseng. |
Family |
: |
Araliaceae |
|
General Info
Description |
|
|
Herbs, perennial, 20-60 cm tall. Rootstock fleshy, roots 1 to numerous, fusiform. Leaves 3-6, verticillate at apex of stem, palmately compound; petiole base without stipule or stipulelike appendages; leaflets obovate or obovate-oblong, 3.5-13 × 1.5-7 cm, membranous, both surfaces sparsely setose on veins, base oblique, margin biserrate, setose, apex acuminate or long acuminate. Inflorescence a solitary, terminal umbel 80-100(or more)-flowered; peduncle 7-25 cm, glabrous or sparsely pubescent; pedicels 1-2 cm, slender, slightly pubescent; filaments ca. as long as petals; ovary 2-carpellate; styles 2, united at least to middle, divergent in fruit. Fruit red, compressed globose-nephroid, ca. 1 cm in diam.; seeds 2, triangular-ovoid, slightly 3-ridged, thickness 5-6 mm. |
Herb Effects |
|
|
Analgesic, anti-inflammatory, antiphlogistic, antiseptic, astringent, cardiotonic, discutient, diuretic, haemostatic, hypoglycaemic, styptic, tonic and vulnerary (roots); antibacterial, anti-inflammatory, antiseptic, cardiotonic, diuretic, haemostatic and hypoglycaemic (roots and flowers) |
Chemistry
Active Ingredients |
|
|
Beta-sitosterol, daucosterol, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Re, ginsenoside Rg1, ginsenoside Rg2, ginsenoside, quercetin (root) |
Chemistry
of Active Ingredients |
|
|
|
|
Name |
CAS# |
IUPAC Name |
Formula |
Structure |
|
|
Beta-sitosterol |
5779-62-4 |
17-(5-ethyl-6-methyl -heptan-2-yl)-10,13- dimethyl-2,3,4,7,8,9 ,11,12,14, |
C29H50O |
|
Daucosterol |
474-58-8 |
2-[[17-(4-ethyl-1,5- dimethyl-hexyl)-10,1 3-dimethyl-2,3,4,7,8 ,9,10,11,1
2,13,14, 15,16,17-tetradecahy dro-1H-cyclopenta[a] phenanthren-3-yl]oxy ]-
6-(hydroxymethyl )tetrahydropyran-3,4 ,5-triol |
C35H60O6 |
|
Ginsenoside Rb1 |
Not Available |
(2R,3R,4S,5R,6R)-2-[ 2-[(3S,8R,10S,13R)-3 -[(2R,3R,4S,5R,6R)-4 ,5-dihydro
xy-6-(hy droxymethyl)-3-[(2R, 3R,4S,5R,6R)-3,4,5-t rihydroxy-6-(hydroxy me
thyl)oxan-2-yl]o xy-oxan-2-yl]oxy-12- hydroxy-4,4,8,10,14- pentamethyl-2,
3,5, 6,7,9,11,12,13,15,16 ,17-dodecahydro-1H-c yclopenta[a]phenanth ren-17
-yl]-6-methy l-hept-5-en-2-yl]oxy -6-[[(2R,3R,4S,5R,6R )-3,4,5-trihydroxy
-6-(hydroxymethyl)ox an-2-yl]oxymethyl]ox ane-3,4,5-triol |
C54H92O23 |
|
Ginsenoside Rb2 |
75139-47-8 |
(2S,3R,5R,6R)-2-[(2S )-2-[(3S,5S,8R,9S,10 S,12R,13R,14R,17S)-3 -[(2R,3R,4
S,5R,6R) -4,5-dihydroxy-6-(hy droxymethyl)-3-[(2S, 3R,4S,5R,6R)-3,4,5-t ri
hydroxy-6-(hydro xymethyl)oxan-2-yl]o xy-oxan-2-yl]oxy-12- hydroxy-4,4,8,
10,1 4-pentamethyl-2,3,5, 6,7,9,11,12,13,15,16 ,17-dodecahydro-1H-c yclope
nta[a]phenan thren-17-yl]-6-methy l-hept-5-en-2-yl]oxy -6-[[(2R,3R,4S,5S)
-3,4,5-trihydroxyoxa n-2-yl]oxymethyl]oxa ne-3,4,5-triol |
C53H90O22 |
|
Ginsenoside Re |
Not Available |
(2S,3R,4S,5R,6R)-2-[ (2S)-2-[(3S,5S,6S,8R ,9R,10R,12R,13R,14R, 17S)-6-[(2
R,3R,4S, 5R,6R)-4,5-dihydroxy -6-(hydroxymethyl)-3 -[(2S,3R,4R,5S,6S)-3 ,4
,5-trihydroxy-6- methyl-oxan-2-yl]oxy -oxan-2-yl]oxy-3,12- dihydroxy-4,4,
8,10 ,14-pentamethyl-2,3, 5,6,7,9,11,12,13,15, 16,17-dodecahydro-1H -cyclo
penta[a]phen anthren-17-yl]-6-met hyl-hept-5-en-2-yl]o xy-6-(hydroxymethy
l)oxane-3,4,5-triol |
C48H82O18 |
|
Ginsenoside RG1 |
75139-45-6 |
2-[2-[3,12-dihydroxy -4,4,7,10,14-pentame thyl-6-[3,4,5-trihyd roxy-6-(hy
droxymet hyl)oxan-2-yl]oxy-1, 2,3,5,6,7,8,9,11,12, 13,15,16,17-tetradec ah
ydrocyclopenta[a ]phenanthren-17-yl]- 6-methyl-hept-5-en-2 -yl]oxy-6-(hyd
roxy methyl)oxane-3,4,5-t riol |
C42H72O14 |
|
Ginsenoside RG2 |
52286-74-5 |
(2S,3R,4R,5S,6S)-2-[ (2R,3R,4S,5R,6R)-2-[ [(6R,10R,12S,14R)-3, 12-dihydro
xy-17-[( E,2S)-2-hydroxy-6-me thyl-oct-5-en-2-yl]- 4,4,10,14-tetramethy l-
1,2,3,5,6,7,8,9, 11,12,13,15,16,17-te tradecahydrocyclopen ta[a]phenanthr
en-6 -yl]oxy]-4,5-dihydro xy-6-(hydroxymethyl) oxan-3-yl]oxy-6-meth yl-oxa
ne-3,4,5-tri ol |
C42H72O13 |
|
Ginsenoside |
74749-74-9 |
(3S,5S,8R,9S,10S,14R ,17S)-17-(2-hydroxy- 6-methyl-hept-5-en-2 -yl)-4,4,8
,10,14-p entamethyl-2,3,5,6,7 ,9,11,12,13,15,16,17 -dodecahydro-1H-cycl op
enta[a]phenanthr en-3-ol |
C30H52O2 |
|
Quercetin |
Not Available |
2-(3,4-dihydroxyphen yl)-3,4,5-trihydroxy -chromen-7-one |
C15H10O7 |
|
|
Pharmacology
Medicinal Use |
|
|
The roots are used in the treatment of contused wounds, soft tissue injuries and all kinds of bleeding, both internal and external, like haematuria, nose bleeds, haematemesis, uterine bleeding etc. They are also used in the treatment of coronary heart disease and angina pectoris. The roots can be applied externally as a poultice in order to help speed the healing of wounds and bruises. It has attained an importance as a tonic medicine that supports the function of the adrenal glands, in particular the production of corticosteroids and male sex hormones. It also helps to improve blood flow through the coronary arteries, thus finding use as a treatment for arteriosclerosis, high blood pressure and angina. |
Reference |
|
|
James A Duke and Maryl Fulton. Handbook of Medicinal Herbs - 2nd Edition, P: 733, CRC Press July 2002. |
Dealers
Products
|
|